Article
Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia.
Leukemia research - 1 Sept 2007
Scholl S, Mügge L-O, Landt O, Loncarevic I F, Kunert C, Clement J H, Höffken K
Abstract excerpt
Nucleophosmin mutations of exon 12 (NPM1 mutations) represent the most frequent molecular aberration that can be found in patients with acute myeloid leukaemia (AML) and can be detected in about 35% of AML patients. NPM1 mutations are characterised by four basepair insertions within the region co...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
